Thursday, January 19, 2017
Ray Dorsey, MD, MBA
Director, Center for Human Experimental Therapeutics (CHET)
David M. Levy Professor of Neurology
University of Rochester Medical Center
About the Presentation
Just as telemedicine is reshaping clinical care, it is poised to reshape clinical trials. New technologies and tools including smartphones, wearable sensors and virtual visits are rapidly changing the way that information is collected in clinical trials. Siteless clinical trials along with objective, sensitive, high frequency assessments gathered outside of research sites are emerging, but the regulatory framework for these tools is less certain. This presentation highlighted these new advances and their application to clinical trials.
About the Presenter
Dr. Ray Dorsey is the David M. Levy Professor of Neurology and Director of CHET at the University of Rochester Medical Center. CHET is a center that seeks to advance knowledge and improve health through ground-breaking research. Through novel applications of technology, Dr. Dorsey and his colleagues seek to enable anyone anywhere to receive care, participate in research, and benefit from therapeutic advances.
Dr. Dorsey previously directed the movement disorders division and neurology telemedicine at Johns Hopkins University and worked as a consultant for McKinsey & Company. Dr. Dorsey’s research has been published in leading medical, neurology, and economic journals and has been featured on National Public Radio and in The New York Times and The Wall Street Journal. In 2015, he was recognized as a White House “Champion for Change” for Parkinson’s disease.